MOTS-C is a mitochondrial-derived peptide encoded within the mitochondrial genome, studied for its interaction with cellular metabolic signalling pathways. PhaseOne supplies MOTS-C to Australian researchers as a high-purity lyophilised powder, independently HPLC verified at ≥98% purity per batch.
As a comparatively newer addition to Australian peptide research, MOTS-C's chemical reference data is less standardised across suppliers than older peptides - researchers are encouraged to cross-check batch documentation directly with PhaseOne's COA records. PhaseOne manufactures MOTS-C to research-grade standards with full third-party testing, shipped Australia-wide. (!) Full Certificate of Analysis available for every batch view here.
MOTS-C is a mitochondrial-derived peptide, distinct from the synthetic analogues that make up most research peptides, studied within Australian peptide research for its role in metabolic signalling.
Laboratory interest in MOTS-C commonly centres on mitochondrial signalling and metabolic regulation research, an emerging area within the broader research peptide field.
Unreconstituted MOTS-C should be stored refrigerated and protected from light, and is commonly reconstituted with bacteriostatic water prior to research use. (!) Read our reconstitution guide.
Each PhaseOne batch is independently verified by third-party HPLC analysis, with a Certificate of Analysis available on request for every order shipped across Australia.
MOTS-C is currently supplied in 10mg vials, shipped Australia-wide with full batch documentation.
MOTS-C's metabolic signalling research is sometimes considered alongside other longer-chain metabolic peptides such as Retatrutide, though the two have distinct mechanisms. (!) View our Retatrutide.
Disclaimer
All products supplied by PhaseOne are intended strictly for laboratory research purposes only. Products are not intended for human consumption, therapeutic use, cosmetic use, veterinary use, or diagnostic applications.
